Innovatus Capital Partners is a Investment Adviser And Portfolio Management Firm.
Innovatus Capital Partners, they focus on both real and financial assets. Their firm's investment in strategies that identifies distressed, disruptive, and growth opportunities.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 7, 2022
Eiger BioPharmaceuticals
|
Post-IPO Debt | $75M | Biotechnology | Yes |
Jun 7, 2022
Eiger BioPharmaceuticals
|
Post-IPO Equity | $5M | Biotechnology | Yes |
Mar 8, 2022
DNAnexus
|
Series H | $200M | Bioinformatics | — |
Feb 6, 2019
DNAnexus
|
Series F | $68M | Bioinformatics | — |